Fig. 3From: Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysisHazard ratio (HR) of Lgr5 overexpression associated with overall survival (OS) in the subgroup of (a) patient sample size, (b) NOS score of study, (c) the Lgr5 assessment method, and (d) patients’ country of originBack to article page